Fatigue in chronic disease

Clinical Science

Volumn 99, Issue 1, 2000, Pages 1-8

  Swain, Mark G ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Anxiety; Corticotropin releasing hormone; Cytokines; Depression; Fatigue; Hypothalamic pituitary adrenal axis; Inflammation; Mood disorder; Neurotransmitter

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CYTOKINE; HYPNOTIC AGENT; NEUROTRANSMITTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC DISEASE; DISEASE SEVERITY; FATIGUE; HUMAN; IMMUNOSTIMULATION; METHODOLOGY; MOOD; NONHUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; STRESS; SYMPTOM; TREATMENT OUTCOME;

EID: 0033910678     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0990001     Document Type: Article

References (101)

1. 1 Hensyl, W. R. (ed.) (1990) Stedman's Medical Dictionary, 25th edn., Williams & Wilkins, Baltimore, MD
2. 2 Lewis, S. F. and Haller, R. G. (1991) Physiologic measurement of exercise and fatigue with special reference to chronic fatigue syndrome. Rev. Infect. Dis. 14, S98-S108
3. 3 Lee, K. A., Hicks, G. and Nino-Murcia, G. (1991) Validity and reliability of a scale to assess fatigue. Psychiatry Res. 36, 291-298
4. 4 Many, P., Lane, T. J. and Mathews, D. A. (1988) The frequency of the chronic fatigue syndrome in patients with symptoms of persistent fatigue. Ann. Intern. Med. 109, 534-556
5. 5 Lloyd, A. R. (1998) Chronic fatigue and chronic fatigue syndrome: shifting boundaries and attributions. Am. J. Med. 105, 75-105
6. 6 Aaronson, L. S., Teel, C. S., Cassmeyer, V. et al. (1999) Defining and measuring fatigue. J. Nurs. Schol. 31, 45-50
7. 7 Piper, B. F. (1989) Fatigue: current bases for practice. In Key Aspects of Comfort (Funk, S. G., Tornquist, E. M., Champagne, M. T., Copp, L. A. and Wiese, R., eds.), pp. 187-198, Springer, New York
8. 8 Bates D. W., Schmitt, W., Buchwald, D. et al. (1993) Prevalence of fatigue and chronic fatigue syndrome in a primary care practice. Arch. Int. Med. 153, 2759-2765
9. 9 Pawlikowska, T., Chalder, T., Hirsch, S. R., Wallace, P., Wright, D. J. M. and Wessely, S. C. (1994) Population based study of fatigue and psychological distress. Br. Med. J. 308, 763-766
10. 10 Buchwald, D., Umali, P., Umali, J., Kith, P., Pearlman, T. and Komaroff, A. (1995) Chronic fatigue and chronic fatigue syndrome: prevalence in a Pacific Northwest health care system. Ann. Intern. Med. 123, 81-88
11. 11 Wessely, S., Chalder, T., Hirsch, S., Pawlikowska, T., Wallace, P. and Wright, D. J. M. (1995) Postinfections fatigue: prospective cohort study in primary care. Lancet 345, 1333-1338
12. 12 Chalder, T., Berelowitz, G., Pawlikowska, T. et al. (1993) Development of a fatigue scale. J. Psychosom. Res. 37, 147-153
13. 13 Krupp, L. B., LaRocca, N. G., Muir-Nash, J. and Steinberg, A. D. (1989) The fatigue severity scale. Arch. Neurol. 46, 1121-1123
14. 14 Schwartz, J. E., Jandorf, L. and Krupp, L. B. (1993) The measurement of fatigue: a new instrument. J. Psychosom. Res. 37, 753-762
15. 15 Vercoulen, J. H., Bazelmans, E., Swanink, C. M. et al. (1997) Physical activity in chronic fatigue syndrome: assessment and its role in fatigue. J. Psychiatr. Res. 31, 661-673
16. 16 Freal, J. G., Kraft, G. H. and Coryell, J. K. (1984) Symptomatic fatigue in multiple sclerosis. Arch. Phys. Med. Rehabil. 5, 135-137
17. 17 Krupp, L. B., Alvarez, L. A., LaRocca, N. G. and Scheinberg, L. C. (1988) Fatigue in multiple sclerosis. Arch. Neurol. 45, 435-437
18. 18 Krupp, L. B., LaRocca, N. G., Muir, J. and Steinberg, A. D. (1990) A study of fatigue in systemic lupus erythematosus. J. Rheumatol. 17, 1450-1452
19. 19 Denburg, S. D., Carbotte, R. M. and Denburg, J. A. (1997) Psychological aspects of systemic lupus erythematosus: cognitive function, mood, and self-report. J. Rheumatol. 24, 998-1003
20. 20 Jones, E. A. (1995) Fatigue associated with chronic liver disease: a riddle wrapped in a mystery inside an enigma. Hepatology 22, 1606-1608
21. 21 Cauch-Dudek, K., Abbey, S., Stewart, D. E. and Heathcote, E. J. (1998) Fatigue in primary biliary cirrhosis. Gut 43, 705-710
22. 22 Huyser, B. A., Parker, J. C., Thoreson, R., Smarr, K. L., Johnson, J. C. and Hoffman, R. (1998) Predictors of subjective fatigue among individuals with rheumatoid arthritis. Arthritis Rheum. 41, 2230-2237
23. 23 Wolfe, F., Hawley, D. J. and Wilson, K. (1996) The prevalence and meaning of fatigue in rheumatic disease. J. Rheumatol. 23, 1407-1417
24. 24 Breitbart, W., McDonald, M. V., Rosenfeld, B., Monkman, N. D. and Passik, S. (1998) Fatigue in ambulatory AIDS patients. J. Pain Symptom Manage. 15, 159-167
25. 25 Taylor, A. and Taylor, R. S. (1998) Neuropsychological aspects of multiple sclerosis. Phys. Med. Rehabil. Clin. N. Am. 9, 643-657
26. 26 Beam, J. and Wessely, S. (1994) Neurobiological aspects of the chronic fatigue syndrome. Eur. J. Clin. Invest. 24, 79-90
27. 27 Shanks, S., Harbuz, M. S., Jessop, D. S., Perks, P., Moore, P. M. and Lightman, S. L. (1998) Inflammatory disease as chronic stress. Ann. N.Y. Acad. Sci. 840, 599-607
28. 28 Chrousos, G. P. and Gold, P. W. (1992) The concepts of stress and stress system disorders. JAMA J. Am. Med. Assoc. 267, 1244-1252
29. 29 Vale, W., Speiss, J., Rivier, C. and Rivier, J. (1981) Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science 213, 1394-1397
30. 30 Swanson, L. W., Sawchenko, P. E., Rivier, J. and Vale, W. W. (1983) Organization of ovine corticotropin-releasing factor immunoreactive cells and fibres in the rat brain: an immunohistochemical study. Neuroendocrinology 36, 165-186
31. 31 Koob, G. F., Heinrichs, S. C., Pich, E. M. et al. (1993) The role of corticotropin-releasing factor in behavioural responses to stress. Ciba Found. Symp. 172, 277-289
32. 32 Sutton, R. E., Koob, G. F., LeMoal, M., Rivier, J. and Vale, W. (1982) Corticotropin-releasing factor produces behavioural activation in rats. Nature (London) 297, 331-333
33. 33 Clauw, D. J. and Chrousos, G. P. (1997) Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation 4, 134-153
34. 34 Bearn, J., Allain, T., Coskeran, P. et al. (1995) Neuroendocrine responses to d-fenfluramine and insulin-induced hypoglycemia in chronic fatigue syndrome. Biol. Psychiatry 37, 245-252
35. 35 Gutierrez, M. A., Garcia, M. E., Rodriguez, J. A., Rivero, S. and Jacobelli, S. (1998) Hypothalamic-pituitary-adrenal axis function and prolactin secretion in systemic lupus erythematosus. Lupus 7, 404-408
36. 36 Gutierrez, M. A., Garcia, M. E., Rodriguez, J. A., Mardonez, G., Jacobelli, S. and Rivero, S. (1999) Hypothalamic-pituitary-adrenal axis function in patients with active rheumatoid arthritis: a controlled study using insulin hypoglycemia stress test and prolactin stimulation. J. Rheumatol. 26, 277-281
37. 37 Klapps, P., Seyfert, S., Fischer, T. and Scherbaum, W. A. (1992) Endocrine function in multiple sclerosis. Acta Neurol. Scand. 85, 353-357
38. 38 Swain, M. G., Mogiakou, M., Bergasa, N. V. et al. (1994) Facilitation of ACTH and cortisol responses to corticotropin-releasing hormone (CRH) in patients with primary biliary cirrhosis. Hepatology 20, 146A
39. 39 Aguilera, G. (1994) Regulation of pituitary ACTH secretion during chronic stress. Front. Neuroendocrinol. 15, 321-350
40. 40 Imaki, T., Nahan, J.-L., Rivier, C., Sawchenko, P. E. and Vale, W. (1991) Differential regulation of corticotropin-releasing factor mRNA in rat brain regions by glucocorticoids and stress. J. Neurosci. 11, 585-599
41. 41 Chappell, P. B., Smith, M. A., Kilts, C. D. et al. (1986) Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress. J. Neurosci. 6, 2908-2914
42. 42 Harbuz, M. S., Rees, R. G., Eckland, D., Jessop, S., Brewerton, D. and Lightman, S. L. (1992) Paradoxical responses of hypothalamic CRF mRNA and CRF-41 peptide and adenohypyphyseal POMC mRNA during chronic inflammatory stress. Endocrinology 130, 1394-1400
43. 43 Harbuz, M. S., Leonard, J. P., Lightman, S. L. and Cuzner, M. L. (1993) Changes in hypothalamic corticotropin releasing factor (CRF) and pituitary proopiomelanocortin (POMC) messenger RNA during the course of experimental allergic encephalomyelitis. J. Neuroimmunol. 45, 127-132
44. 44 Swain, M. G., Patchev, V., Vergalla, J., Chrousos, G. and Jones, E. A. (1993) Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis. J. Clin. Invest. 91, 1903-1908
45. 45 Swain, M. G. and Maric, M. (1995) Defective corticotropin-releasing hormone mediated neuroendocrine and behavioural responses in cholestatic rats: implications for cholestatic liver disease-related sickness behaviours. Hepatology 22, 1560-1564
46. 46 Kent, S., Bluthe, R.-M., Kelley, K. W. and Dantzer, R. (1992) Sickness behaviour as a new target for drug development. Trends Pharmacol. Sci. 13, 24-28
47. 47 Arvidson, N. G., Gudbjornsson, B., Elfman, L., Ryden, A.-C, Tötterman, T. H. and Hallgren, R. (1994) Circadian rhythm of serum interleukin-6 in rheumatoid arthritis. Ann. Rheum. Dis. 53, 521-524
48. 48 Davas, E. M., Tsirogianni, A., Kappou, I., Karamitsos, D., Economidou, I. and Dantis, P. C. (1999) Serum IL-6, TNFα, p55sr TNFα, p75sr TNFα, srIL-2α levels and disease activity in systemic lupus crythematosus. Clin. Rheumatol. 18, 17-22
49. 49 Rovaris, M., Barnes, D., Woodrofe, N. et al. (1996) Patterns of disease activity in multiple sclerosis patients: a study with quantitative gadolinium-enhanced brain MRI and cytokine measurement in different clinical subgroups. J. Neurol. 243, 536-542
50. 50 Tilg, H., Wilmer, A., Vogel, W. et al. (1992) Serum levels of cytokines in chronic liver diseases. Gastroenterology 103, 264-271
51. 51 Kent, S., Bluthe, R.-M., Dantzer, R. et al. (1992) Different receptor mechanisms mediate the pyrogenic and behavioural effects of interleukin-1. Proc. Natl. Acad. Sci. U.S.A. 89, 9117-9120
52. 52 Spadaro, F. and Dunn, A. J. (1990) Intracerebroventricular administration of interleukin-1 to mice alters investigation of stimuli in a novel environment. Brain Behav. Immun. 4, 308-322
53. 53 Turnbull, A. V. and Rivier, C. L. (1999) Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol. Rev. 79, 2-43
54. 54 Rothwell, N. J. (1997) Neuroimmune interactions: the role of cytokines. Br. J. Pharmacol. 121, 841-847
55. 55 Swain, M. G., Beck, P. L., Rioux, K. and Le, T. (1998) Augmented interleukin-1β-induced depression of locomotor activity in cholestatic rats. Hepatology 28, 1561-1565
56. 56 Sapolsky, R., Rivier, C., Yamamoto, G., Plotsky, P. and Vale, W. (1987) Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 238, 522-524
57. 57 Chikanza, I. C., Petrou, P., Kingsley, G., Chrousos, G. and Panayi, G. S. (1992) Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum. 35, 1281-1288
58. 2 release. Am. J. Physiol. 258, G404-G409
59. 59 Vgontzas, A. N., Papanicolqou, D. A., Bixler, E. O., Kales, A., Tyson, K. and Chrousos, G. P. (1997) Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J. Clin. Endocrinol. Metab. 82, 1313-1316
60. 60 Papanicolaou, D. A., Wilder, R. L., Manolagas, S. C. and Chrousos, G. P. (1998) The pathophysiologic roles of interleukin-6 in human disease. Ann. Intern. Med. 128, 127-137
61. 61 Gordon, M. S., Nemunaitis, J., Hoffman, R. et al. (1995) A phase I trial of recombinant human interleukin-6 in patients with melodysplastic syndromes and thrombocytopenia. Blood 85, 3066-3076
62. 62 Plevris, J. N., Blair, C., Cossar, J. A., Dollinger, M. M., O'Carroll, R. E. and Hayes, P. C. (1997) Chronic fatigue is associated with increased interleukin-6 levels in patients with chronic liver disease. Hepatology 26, A1818
63. 63 Sasai, M., Saeki, Y., Ohshima, S. et al (1999) Delayed onset and reduced severity of collagen-induced arthritis in interleukin-6 deficient mice. Arthritis Rheum. 42, 1635-1643
64. 64 Okuda, Y., Sakoda, S. and Yanagihara, T. (1998) The pattern of cytokine gene expression in lymphoid organs and peripheral blood mononuclear cells of mice with experimental allergic encephalomyelitis. J. Neuroimmunol. 87, 147-155
65. 65 Suzuki, H., Yasukawa, K., Saito, T. et al. (1993) Serum soluble interleukin-6 receptor in MRL/1pr mice is elevated with age and mediates the interleukin-6 signal. Eur. J. Immunol. 23, 1078-1082
66. 66 Bemelmans, M. H., Gouma, D. J., Greve, J. W. and Buurman, W. A. (1992) Cytokines tumour necrosis factor and interleukin-6 in experimental biliary obstruction in mice. Hepatology 15, 1132-1136
67. 67 Wang, J. and Dunn, A. J. (1998) Mouse interleukin-6 stimulates the HPA axis and increases brain tryptophan and serotonin metabolism. Neurochem. Int. 33, 143-154
68. 68 Vallieres, L. and Rivest, S. (1999) Interleukin-6 is a needed proinflammatory cytokine in the prolonged neural activity and transcriptional activation of corticotropin-releasing factor during endotoxemia. Endocrinology 140, 3890-3903
69. 69 Dusheiko, G. (1997) Side effects of alpha interferon in chronic hepatitis C. Hepatology 26, 112S-121S
70. 70 Calogero, A. E., Bagdy, G., Szemeredi, K., Tartaglia, M. E., Gold, P. W. and Chrousos, G. P. (1990) Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat. Endocrinology 126, 1888-1894
71. 71 Koob, G. F. (1999) Corticotropin-releasing factor, norepinephrine and stress. Biol. Psychiatry 46, 1167-1180
72. 72 Liposits, Z., Phelix, C. and Paull, W. (1987) Synaptic interaction of serotonergic axons and corticotropin-releasing factor (CRF) synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. Histochemistry 86, 541-549
73. 73 Roth, B. L. (1994) Multiple serotonin receptors: clinical and experimental aspects. Ann. Clin. Psychiatry 6, 67-78
74. 74 Bakheit, A. M. O., Behan, P. O., Dinan, T. G., Gray, C. E. and O'Keane, V. (1992) Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome. Br. Med. J. 304, 1010-1012
75. 75 Goldenberg, D., Mayskiy, M., Mossey, C., Ruthazer, R. and Schmid, C. (1996) A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum. 39, 1852-1859
76. 76 Wearden, A. J., Morriss, R. K., Mullis, R. et al. (1998) Randomized, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome. Br. J. Psychiatry 172, 485-490
77. 77 Bailey, S. P., Davis, J. M. and Ahlborn, E. N. (1993) Neuroendocrine and substrate responses to altered brain 5-HT activity during prolonged exercise to fatigue. J. Appl. Physiol. 74, 3006-3012
78. 78 Wilson, W. M. and Maughan, R. J. (1992) Evidence for a possible role of 5-hydroxytryptamine in the genesis of fatigue in man: administration of paroxetine, a 5-HT re-uptake inhibitor, reduces the capacity to perform prolonged exercise. Exp. Physiol. 77, 921-924
79. 79 Swain, M. G. and Maric, M. (1997) Improvement in cholestasis-associated fatigue with a serotonin receptor agonist using a novel rat model of fatigue assessment. Hepatology 25, 291-294
80. 80 Jones, E. A. (1999) Relief from profound fatigue associated with chronic liver disease by long-term ondansetron therapy. Lancet 357, 397
81. 81 Wilde, M. I. and Markham, A. (1996) Ondansetron: a review of its pharmacology and preliminary clinical findings in novel applications. Drugs 52, 773-794
82. 82 Russell, I. J., Orr, M. D., Littman, B. et al. (1994) Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum. 37, 1592-1601
83. 83 Chowdrey, H. S., Larsen, P. J., Harbuz, M. S., L.ightman, S. L. and Jessop, D. S. (1995) Endogenous substance P inhibits the expression of corticotropin-releasing hormone during a chronic inflammatory stress. Life Sci. 57, 2021-2029
84. 84 Larsen, P. J., Jessop, D., Patel, H., Lightman, S. L. and Chowdrey, H. S. (1993) Substance P inhibits the release of anterior pituitary adrenocorticotrophin via a central mechanism involving corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus. J. Neuroendocrinol. 5, 99-105
85. 85 Hickie, I., Lloyd, A., Wakefield, D. and Parker, G. (1990) The psychiatric status of patients with chronic fatigue syndrome. Br. J. Psychiatry 156, 534-540
86. 86 Wood, G. C., Bentall, R. P., Gopfert, M. and Edwards, R. H. T. (1991) A comparative psychiatric assessment of patients with chronic fatigue syndrome and neuromuscular disease. Psychol. Med. 21, 619-628
87. 87 Sakic, B., Laflamme, N., Crnic, L. S., Szechtman, H., Denburg, J. A. and Rivest, S. (1999) Reduced corticotropin-releasing factor and enhanced vasopressin gene expression in brains of mice with autoimmunity-induced behavioural dysfunction. J. Neuroimmunol. 96, 80-91
88. 88 Swain, M. G. and Marie, M. (1998) Chronic cholestasis in rats induces anhedonia and a loss of social interest. Hepatology 28, 6-10
89. 89 Cook, N. F. and Boore, J. R. P. (1997) Managing patients suffering from acute and chronic fatigue. Br. J. Nurs. 6, 811-815
90. 90 Piper, B. F. (1986) Fatigue. In Pathophysiological Phenomena in Nursing: Human Response to Illness (Carrieri, V. K., Lindsey, A. M. and West, L. H., eds.), pp. 219-233, WB Saunders, Philadelphia
91. 91 Graydon, J. E., Bubela, N., Irvine, D. and Vincent, L. (1995) Fatigue-reducing strategies used by patients receiving treatment for cancer. Cancer Nurs. 18, 23-28
92. 92 Wearden, A. J., Morris, R. K., Mullis, R. et al. (1998) Randomised, double blind, placebo controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome. Br. J. Psychiatry 172, 485-490
93. 93 Sharpe, M. (1998) Cognitive behaviour therapy for chronic fatigue syndrome: efficacy and implications. Am. J. Med. 105, 1045-1095
94. 94 Deale, A., Chalder, T., Marks, I. and Wessely, S. (1997) Cognitive behaviour therapy for chronic fatigue syndrome: a randomized controlled trial. Am. J. Psychiatry 154, 408-414
95. 95 Sinclair, V. G., Wallston, K. A., Dwyer, K. A., Blackburn, D. S. and Fuchs, H. (1998) Effects of cognitive-behavioural intervention for women with rheumatoid arthritis. Res. Nurs. Health 21, 315-326
96. 96 Shapiro, C. M., Devins, G. M. and Hussain, M. R. G. (1993) Sleep problems in patients with medical illness. Br. Med. J. 306, 1532-1535
97. 97 Ferini-Strambi, L., Filippi, M., Martinelli, V. et al. (1994) Nocturnal sleep study in multiple sclerosis: correlations with clinical and brain magnetic resonance imaging findings. J. Neurol. Sci. 125, 194-197
98. 98 Valencia-Flores, M., Resendiz, M., Castano, V. A. et al. (1999) Objective and subjective sleep disturbances in patients with systemic lupus erythematosus. Arthritis Rheum. 42, 2189-2193
99. 99 Hirsch, M., Carlander, B., Verge, M. et al. (1994) Objective and subjective sleep disturbances in patients with rheumatoid arthritis. Arthritis Rheum. 37, 41-19
100. 100 Devins, G. M., Edworthy, S. M., Paul, L. C. et al. (1993) Restless sleep, illness intrusiveness and depressive Symptoms in three chronic illness conditions: rheumatoid arthritis, end-stage renal disease and multiple sclerosis. J. Psychosom. Res. 37, 163-170
101. 101 Cauch-Dudek, K., Heathcote, E. J., Huterer, N., Driver, H. and Shapiro, C. (1998) Is disturbed sleep, based on objective polysomnographic indicators, a factor in the fatigue of patients with primary biliary cirrhosis? Hepatology 28, A1524